期刊选题

1、投稿方式：在线投稿。

2、官网网址：

https://onlinelibrary.wiley.com/journal/25742272

http://pi.yiigle.com/

投稿系统：

https://mc.manuscriptcentral.com/ped4

3、官网邮箱：

pieditorial@pediatricinvestigation.org（编辑部）

4、官网电话：010-66019629

5、出刊日期：季刊，逢季末月出版。

2021年5月13日星期四

《儿科学研究（英文）》投稿指南

【官网信息】

Authors Guidelines for Pediatric Investigation

1. Submission

2. Aims and Scope

3. Manuscript Categories and Requirements

4. Preparing Your Submission

5. Editorial Policies and Ethical Considerations

6. Open Access License and Copyright

7. Publication Process after Acceptance

8. Post Publication

9. Editorial Office Contact Details

1. SUBMISSION

Thank

you for your interest in Pediatric Investigation. Note that submission

implies that the content has not been published or submitted for

publication elsewhere except as a brief abstract in the proceedings of a

scientific meeting or symposium.

Once

you have prepared your submission in accordance with the Guidelines,

manuscripts should be submitted online at

https://mc.manuscriptcentral.com/ped4.

The

submission system will prompt you to use an ORCID iD (a unique author

identifier) to help distinguish your work from that of other

researchers. Click here to find out more.

Click here for more details on how to use ScholarOne.

For help with submissions, please contact: pieditorial@pediatricinvestigation.org.

We look forward to your submission.

2. AIMS AND SCOPE

Pediatric

Investigation serves to disseminate the cutting-edge knowledge on

clinical observations of pediatric research. It focuses on clinical

care, clinical practice and translational medicine in the field. The

editors encourage contributions relating to pediatric internal medicine,

surgery, radiology, pathology, biochemistry, physiology, sociology and

history, preventive healthcare, pharmacology and many pediatric

subspecialties.

Pediatric

Investigation considers unsolicited manuscripts in the following

categories: Original Article, Review Article, Commentary, Case Report

and Brief Report. The editors will also invite manuscripts to publish in

the special feature columns: Editorial, Guidelines, Consensus or

Recommendations, Medical News, Lecture, Workshop, Journal Club,

Characters in Pediatrics, and Clinical Experience.

Keywords: Pediatrics, Pediatric subspecialties, cutting-edge knowledge, Research, Guidelines

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Editorial

Word limit: 1200 words maximum excluding references, tables and figures.

Abstract: not required. References: 20 maximum, including the article discussed. Figures/tables: 1 maximum.

Description:

Editorials are usually solicited, however, unsolicited editorials are

also welcome. Editorials usually discuss a paper published in the same

or a specific issue of the journal for further understanding and

research.

Original Article

Word limit: 4000 words maximum including abstract but excluding references, tables and figures.

Abstract:

250 words maximum, with sub-headers: Importance, Objective, Methods,

Results, Interpretation. The main text of Original Article should be

structured using the following sections: Introduction, Methods, Results,

Discussion.

References: no limit.

Figures/tables: figures plus tables should not exceed 8.

Description:

Full-length reports of current research in either clinical research or

basic science with the latter having certain potential of clinical

application.

Review

Word limit: 5000 words maximum including abstract but excluding references, tables and figures.

Abstract: 250 words maximum, unstructured (no use of sub-headers).

References: no limit.

Figures/tables: minimum 1 image or figure.

Description:

Reviews are comprehensive analyses of specific topics. Proposals for

reviews may be submitted; however, in this case authors should only send

an outline of the proposed paper for initial consideration. Both

solicited and unsolicited review articles will undergo peer review prior

to acceptance.

Study Protocols

Word limit: 4000 words maximum including abstract but excluding references, tables and figures.

Abstract:

250 words maximum, with sub-headers: Background, Methods, Discussion.

Registration details (trial registration number and date of

registration) should be included as the last line, if appropriate.

Description:

Study Protocols can be for proposed or ongoing research, and should

provide a detailed account of the hypothesis, rationale and methodology

of the study. Protocols of randomized controlled trials should follow

the CONSORT guidelines and must have a trial registration number

included.

Meta-Analysis or Systematic Review

Word limit: 5000 words maximum including abstract but excluding references, tables and figures.

Abstract:

250 words maximum, with sub-headers: Importance, Objective, Methods,

Results, Interpretation. The main text should be structured as:

Introduction, Methods, Results, Discussion.

References: no limit.

Commentary

Word limit: 1500 words maximum excluding references tables and figures.

Abstract: not required.

References: 20 maximum, including the article discussed.

Figures/tables: 2 maximum.

Description:

Commentaries, upon Editor’s invitation, discuss a paper published in a

specific issue and should set the problems addressed by the paper in the

wider context of the field. Proposals for Commentaries may be

submitted; however, in this case authors should only send an outline of

the proposed paper for initial consideration.

Case Report

Word

limit: 1500 words maximum excluding references, tables and figures. An

abstract of about 100 words composed of Introduction, Case Presentation

and Conclusion is needed.

References: 20 maximum.

Figures/tables: 4 maximum.

Description:

New observations of diseases, clinical findings or novel/unique

treatment outcomes relevant to practitioners in pediatric research. The

text should be arranged as follows: Introduction, Case Report, and

Discussion. Only cases of exceptional interest and novelty are

considered.

Brief Report

Word limit: 2000 words including abstract but excluding references, tables and figures.

Abstract: 150 words maximum, unstructured (no use of sub-headers).

References: 35 maximum.

Figures/tables: 4 maximum.

Description:

Manuscripts containing pertinent and interesting observations

concerning pediatric research and reports on new observations or studies

that do not warrant publication as a full research article will be

considered for the Brief Reports. These submissions will undergo full

peer review.

Guidelines, Consensus or Position Paper and Recommendation

Word limit: 5000 words maximum including abstract but excluding references, tables and figures.

Abstract: 250 words maximum, unstructured (no use of sub-headers).

References: no limit.

Figures/tables: minimum 1 image or figure.

Description:

Guidelines, consensus or recommendations need to be the product of a

large group of individuals who are recognized authorities in their

field. They will be written by a working party to include a steering

committee (usually at least 4 members) and other authors representing a

wide range of those with special relevant expertise as well as those

whose everyday practice will be influenced by the guidelines, consensus

or recommendations.

News

Word limit: 500 words maximum.

Abstract: not required.

References: 5 maximum.

Figures: 2 maximum.

Description:

Proposals for Medical News may be submitted; however, in this case

authors should only send an outline of the proposed paper for initial

consideration.

Lecture

Word limit: 5000 words maximum, may or may not include abstract but excluding references, tables and figures.

Abstract: 150 words, unstructured (no use of sub-headers).

References: 35 maximum.

Figures/tables: 4 maximum.

Description:

Manuscripts containing pertinent designs and methods concerning

clinical and translational studies will be considered for the

Lecture/Workshop.

Journal Club

Word limit: 1000 words maximum excluding references, tables and figures.

Abstract: not required.

References: 20 maximum, including the article discussed.

Figures/tables: 2 maximum.

Description:

Manuscripts discuss a high-quality paper published recently in other

journals and should set the problems addressed by the paper in the wider

context of the field. Proposals for Journal Club may be submitted;

however, in this case authors should only send an outline of the

proposed paper for initial consideration.

Clinical Experience

Word limit: Maximum 2000 words including abstract but excluding references, tables and figures.

Abstract: 150 words, unstructured (no use of sub-headers). References: 35 maximum.

Figures/tables: 4 maximum.

Description:

Manuscripts containing pertinent and interesting thoughts and practices

concerning clinical experience will be considered for the Clinical

Experience.

Short Communication

Word limit: 2000 words maximum excluding references, tables and figures. No abstract is needed.

References: 20 maximum.

Figures/tables: 2 maximum.

Description: Manuscripts concerning pediatric patient care will be considered for this column.

Letter to the Editor

Word limit: 400 words maximum excluding references, tables and figures. No abstract is needed.

References: 5 maximum.

Figure/table: 1 maximum.

Description:

Manuscripts pertaining to or not pertaining to articles published in

Pediatric Investigation within the past 2 months will be considered for

this column.

4. PREPARING YOUR SUBMISSION

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures.

The

main text file should be presented in the following order: (i) title,

abstract and keywords, (ii) main text, (iii) references, (iv) tables

(each table complete with title and footnotes), (v) figure legends, (vi)

appendices (if relevant). Figures and supporting information should be

supplied as separate files.

The

manuscript should be prepared using Times New Roman, 12, double-space,

with page numbers and line numbers continuous from the title page,

Title page

The title page should contain:

(i)

A short informative title of less than 20 words (100 characters) that

contains the major keywords. The title should not contain abbreviations

(see Wiley's best practice SEO tips);

(ii) The full names of the authors;

(iii) The author's institutional affiliations at which the work was carried out;

(iv) A running title of less than 50 characters;

(v) The contact information of corresponding author.

The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Authorship

Please

refer to the journal’s authorship policy the Editorial Policies and

Ethical Considerations section for details on eligibility for author

listing.

Abstract

The

abstract should adhere to the word count specifications under the

section Manuscript Categories and Requirements. It should state the main

problem, methods, results, and conclusions. It must be factual and

comprehensive. The use of abbreviations and acronyms should be limited

and general statements (e.g. ‘‘the significance of the results is

discussed’’) should be avoided.

Keywords

Please

provide three to five keywords. Keywords should be taken from those

recommended by the US National Library of Medicine's Medical Subject

Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.

Text

Authors

should use the subheadings required for the Article Type as specified

in the section 'Manuscript Categories and Requirements'.

Acknowledgments

Contributions

from anyone who does not meet the criteria for authorship should be

listed, with permission from the contributor, in the Acknowledgments

section. Financial and material support should also be mentioned. Thanks

to anonymous reviewers are not appropriate.

Ethics

Approval and Consent to Participate: Manuscripts reporting studies

involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)

include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

Studies involving animals must include a statement on ethics approval.

If

your manuscript does not report on or involve the use of any animal or

human data or tissue, please state “Not applicable” in this section.

Consent

for Publication: If your manuscript contains any individual person’s

data in any form (including any individual details, images or videos),

consent for publication must be obtained from that person, or in the

case of children, their parent or legal guardian. All presentations of

case reports must have consent for publication.

You

can use your institutional consent form or our consent form if you

prefer. You do not need to provide a copy of the consent form to the

publisher, however in signing the author license to publish authors are

required to confirm that consent has been obtained.

If your manuscript does not contain data from any individual person, please state “Not applicable” in this section.

Conflict of Interest Statement

You

will be asked to provide a conflict of interest statement during the

submission process. See the section ‘Conflict of Interest’ in the

Editorial Policies and Ethical Considerations section for details on

what to include in this section. Please ensure you liaise with all

co-authors to confirm agreement with the final statement. This section

should be placed after the main text and before the references.

References

We use the Chinese Medical Association system of referencing with modification, see the following for details.

• All references should be numbered consecutively in order of appearance and should be as complete as possible.

• In text citations should cite references in consecutive order using Arabic superscript numerals.

•

For cited journal articles, if there are less than six (including six)

authors, all their names should be listed; if there are more than six

authors, the first six authors’ names are required and followed by “et

al”.

Sample references follow:

In-Text examples:

Diabetes mellitus is associated with a high risk of foot ulcers.1-3

Several interventions have been successful at increasing compliance.11,14-16

The data of Smith et al18 are further evidence of this effect.

As reported previously,1,3-6

The results were as follows4:

Journal article (1-6 authors): list all the authors.

1.

King VM, Armstrong DM, Apps R. Numerical aspects of pontine, lateral

reticular, and inferior olivary projections to two paravermal cortical

zones of the cat cerebellum. J Comp Neurol. 1998;390:537-551.

Journal article with more than six authors: list the first six authors followed by "et al".

2.  Newman MP, Blum S, Wong RC, Scott JG, Prain K, Wilson RJ, et al. Autoimmune encephalitis. Int Med J. 2016;46:148-157.

Journal article with no named author or group name:

3.

Centers for Disease Control and Prevention (CDC). Licensure of a

meningococcal conjugate vaccine (Menveo) and guidance for use--Advisory

Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly

Rep. 2010;59(9):273.

Online articles not yet published in an issue:

4.Smith JJ, Fihn SD, White RH. Treatment of allergic rhinitis. Am J Med. In press.

Book:

5. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990: 1223.

Book chapter:

6.

Guyton JL, Crockarell JR. Fractures of acetabulum and pelvis. In:

Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. Philadelphia,

PA: Mosby, Inc; 2003:2939-2984.

Electronic book:

7. Rudolph CD, Rudolph AM. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw-Hill Companies; 2002.

http://online.statref.com/Document/Document.aspx?DocID=1&StartDoc=1&EndDoc=1882&FxID=13&offset=7&SessionId=A3F279FQVVFXFSXQ

. Accessed August 22, 2007.

Internet document:

8. American Cancer Society. Cancer Facts & Figures 2003.

http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts/Medline.

Tables

Tables

should be self-contained and complement, but not duplicate, information

contained in the text. They should be supplied as editable files, not

pasted as images. Legends should be concise but comprehensive – the

table, legend and footnotes must be understandable without reference to

the text. All abbreviations must be defined in footnotes. Footnote

symbols: †, ‡, §, ¶, should be used (in that order) and *, **, ***

should be reserved for P-values. Statistical measures such as SD or SEM

should be identified in the headings.

Figure Legends

Legends

should be concise but comprehensive – the figure and its legend must be

understandable without reference to the text. Include definitions of

any symbols used and define/explain all abbreviations and units of

measurement.

Preparing Figures

Although

we encourage authors to send us the highest-quality figures possible,

for peer-review purposes we are happy to accept a wide variety of

formats, sizes, and resolutions. The figures should be provided

separately, not integrated into the text file.

Click

here for the basic figure requirements for figures submitted with

manuscripts for initial peer review, as well as the more detailed

post-acceptance figure requirements.

Color

figures: Figures submitted in color may be reproduced in color online

free of charge. Please note, however, that it is preferable that line

figures (e.g. graphs and charts) are supplied in black and white so that

they are legible if printed by a reader in black and white.

Appendices

Appendices

will be published online after the references. For submission they

should be supplied as separate files but referred to in the text.

Supporting Information

Supporting

information is information that is not essential to the article but

that provides greater depth and background. It is hosted online, and

appears without editing or typesetting. It may include tables, figures,

videos, datasets, etc. Click here for Wiley’s FAQs on supporting

information.

Note,

if data, scripts or other artefacts used to generate the analyses

presented in the paper are available via a publicly available data

repository, authors should include a reference to the location of the

material within their paper.

General Style Points

The following links provide general advice on formatting and style.

•

Abbreviations: In general, terms should not be abbreviated unless they

are used repeatedly and the abbreviation is helpful to the reader.

Initially use the term in full, followed by the abbreviation in

parentheses. Thereafter use the abbreviation only.

• Units

of measurement: Measurements should be given in SI or SI-derived units.

Visit the Bureau International des Poids et Mesures (BIPM) website at

http://www.bipm.fr for more information about SI units.

•

Numbers: numbers under 10 are spelt out, except for: measurements with a

unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11

dogs, 9 cats, 4 gerbils).

•

Trade Names: Chemical substances should be referred to by the generic

name only. Trade names should not be used. Drugs should be referred to

by their generic names. If proprietary drugs have been used in the

study, refer to these by their generic name, mentioning the proprietary

name, and the name and location of the manufacturer, in parentheses.

•

Spelling: The journal uses US spelling, however authors may submit

using either option as spelling of accepted papers is converted during

the production process.

•

Footnotes: Footnotes to the text are not allowed and any such material

should be incorporated into the text as parenthetical matter.

Wiley Author Resources

Wiley

has a range of resources for authors preparing manuscripts for

submission available (http://www.wileyauthors.com/prepare). In

particular, authors may benefit from referring to Wiley’s best practice

tips on Writing for Search Engine Optimization.

Article Preparation Support

Wiley

Editing Services offers expert help with English Language Editing, as

well as translation, manuscript formatting, figure illustration, figure

formatting, and graphical abstract design – so you can submit your

manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Editorial Review and Acceptance

The

acceptance criteria for all papers are the quality and originality of

the research and its significance to our readership. Except where

otherwise stated, manuscripts are single-blind peer reviewed. Papers

will only be sent to review if the Editor-in-Chief determines that the

paper meets the appropriate quality and relevance requirements.

Wiley's policy on confidentiality of the review process is available at  http://www.wileypeerreview.com/reviewpolicy.

Manuscripts

are assigned sequentially to Associate Editors. An Associate Editor

solicits reviewers (typically, two external reviews are sought). The

reviewers’ evaluations and Associate Editor’s comments are compiled by

the Editor-in-Chief for disposition and transmittal to the authors.

The

Editor-in-Chief will advise authors whether a manuscript is accepted,

should be revised or is rejected. Minor revisions are expected to be

returned within four weeks of decision; major revisions within three

months. Manuscripts not revised within these time periods are subject to

withdrawal from consideration for publication unless the authors can

provide extenuating circumstances.

A

number of manuscripts will have to be rejected on the grounds of

priority and available space. A manuscript may be returned to the

authors without outside review if the Editor-in-Chief and Associate

Editor find it inappropriate for publication in the Journal. Similarly,

the Editors may expedite the review process for manuscripts felt to be

of high priority in order to reach a rapid decision. Such ‘fast-track

decisions’ will normally occur within one week of receipt of the

manuscript.

The

Editor-in-Chief’s decision is final. If, however, authors dispute a

decision and can document good reasons why a manuscript should be

reconsidered, a rebuttal process exists. In the first place, authors

should write to the Editor-in-Chief.

If

manuscripts are submitted by an Editor, they will be assigned to and

processed by other Editors to avoid conflicts of interest.

Pediatric

Investigation employs a plagiarism detection system. By submitting your

manuscript to this journal, you accept that your manuscript may be

screened for plagiarism against previously published works.

Data Storage and Documentation

Pediatric

Investigation encourages data sharing wherever possible, unless this is

prevented by ethical, privacy or confidentiality matters. Authors

publishing in the journal are therefore encouraged to make their data,

scripts and other artefacts used to generate the analyses presented in

the paper available via a publicly available data repository, however

this is not mandatory. If the study includes original data, at least one

author must confirm that he or she had full access to all the data in

the study, and takes responsibility for the integrity of the data and

the accuracy of the data analysis.

Human Studies and Subjects

For

manuscripts reporting medical studies involving human participants, we

require a statement identifying the ethics committee that approved the

study, and that the study conforms to recognized standards, for example:

Declaration of Helsinki; US Federal Policy for the Protection of Human

Subjects; or European Medicines Agency Guidelines for Good Clinical

Practice.

Images

and information from individual participants will only be published

where the authors have obtained the individual's free prior informed

consent. Authors do not need to provide a copy of the consent form to

the publisher, however in signing the author license to publish authors

are required to confirm that consent has been obtained. Wiley has a

standard patient consent form available for use. The Chinese version is

also available.

Animal Studies

A

statement indicating that the protocol and procedures employed were

ethically reviewed and approved, and the name of the body giving

approval, must be included in the Methods section of the manuscript. We

encourage authors to adhere to animal research reporting standards, for

example the ARRIVE reporting guidelines for reporting study design and

statistical analysis; experimental procedures; experimental animals and

housing and husbandry. Authors should also state whether experiments

were performed in accordance with relevant institutional and national

guidelines and regulations for the care and use of laboratory animals:

US

authors should cite compliance with the US National Research Council's

Guide for the Care and Use of Laboratory Animals, the US Public Health

Service's Policy on Humane Care and Use of Laboratory Animals, and Guide

for the Care and Use of Laboratory Animals.

UK

authors should conform to UK legislation under the Animals (Scientific

Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

European authors outside the UK should conform to Directive 2010/63/EU.

Clinical Trial Registration

We

require that clinical trials are prospectively registered in a publicly

accessible database and clinical trial registration numbers should be

included in all papers that report their results. Please include the

name of the trial register and your clinical trial registration number

at the end of your abstract. If your trial is not registered, or was

registered retrospectively, please explain the reasons for this.

Research Reporting Guidelines

Accurate

and complete reporting enables readers to fully appraise research,

replicate it, and use it. We encourage authors to adhere to the

following research reporting standards.

Authors are encouraged to ensure their manuscript conforms to accepted best practice guidelines such as:

CONSORT guidelines for reports of randomized trials and cluster randomized trials

STROBE statement for observational studies (cohort, case-control, or cross-sectional designs)

STARD guidelines for studies of diagnostic accuracy

PRISMA guidelines for systematic reviews and meta-analyses: Complete PRISMA checklist

COREQ guidelines for qualitative studies: Complete COREQ checklist

CARE guidelines for case reports

See http://www.equator-network.org/ for other study types.

Conflict of Interest

The

journal requires that all authors disclose any potential sources of

conflict of interest. Any interest or relationship, financial or

otherwise that might be perceived as influencing an author's objectivity

is considered a potential source of conflict of interest. These must be

disclosed when directly relevant or directly related to the work that

the authors describe in their manuscript. Potential sources of conflict

of interest include, but are not limited to, patent or stock ownership,

membership of a company board of directors, membership of an advisory

board or committee for a company, and consultancy for or receipt of

speaker's fees from a company. The existence of a conflict of interest

does not preclude publication. If the authors have no conflict of

interest to declare, they must also state this at submission. It is the

responsibility of the corresponding author to review this policy with

all authors and collectively to disclose with the submission ALL

pertinent commercial and other relationships.

Funding

Authors

should list all funding sources in the Acknowledgments section. Authors

are responsible for the accuracy of their funder designation. If in

doubt, please check the Open Funder Registry for the correct

nomenclature: http://www.crossref.org/fundingdata/registry.html

Authorship

The

list of authors should accurately illustrate who contributed to the

work and how. All those listed as authors should qualify for authorship

according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2. Been involved in drafting the manuscript or revising it critically for important intellectual content;

3.

Given final approval of the version to be published. Each author should

have participated sufficiently in the work to take public

responsibility for appropriate portions of the content; and

4.

Agreed to be accountable for all aspects of the work in ensuring that

questions related to the accuracy or integrity of any part of the work

are appropriately investigated and resolved.

Contributions

from anyone who does not meet the criteria for authorship should be

listed, with permission from the contributor, in an Acknowledgments

section (for example, to recognize contributions from people who

provided technical help, collation of data, writing assistance,

acquisition of funding, or a department chairperson who provided general

support). Prior to submitting the article all authors should agree on

the order in which their names will be listed in the manuscript.

Additional authorship options

Joint

first or senior authorship: In the case of joint first authorship a

footnote should be added to the author listing, e.g. ‘X and Y should be

considered joint first author’ or ‘X and Y should be considered joint

senior author.’

Wiley’s Author Name Change Policy

In

cases where authors wish to change their name following publication,

Wiley will update and republish the paper and redeliver the updated

metadata to indexing services. Our editorial and production teams will

use discretion in recognizing that name changes may be of a sensitive

and private nature for various reasons including (but not limited to)

alignment with gender identity, or as a result of marriage, divorce, or

religious conversion. Accordingly, to protect the author’s privacy, we

will not publish a correction notice to the paper, and we will not

notify co-authors of the change. Authors should contact the journal’s

Editorial Office with their name change request.

ORCID

As

part of our commitment to supporting authors at every step of the

publishing process, Pediatric Investigation requires the submitting

author (only) to provide an ORCID iD when submitting a manuscript. This

takes around 2 minutes to complete. Find more information at

http://olabout.wiley.com/WileyCDA/Section/id-828034.html.

Publication Ethics

This

journal is a member of the Committee on Publication Ethics (COPE). Note

that this journal uses iThenticate’s CrossCheck software to detect

instances of overlapping and similar text in submitted manuscripts. Read

our Top 10 Publishing Ethics Tips for Authors at

http://www.wileyauthors.com/ethics. Wiley’s Publication Ethics

Guidelines can be found at

https://authorservices.wiley.com/ethics-guidelines/index.html.

6. OPEN ACCESS LICENSE AND COPYRIGHT

Pediatric

Investigation is an Open Access journal, all articles will be

immediately and permanently free for everyone to read and download. To

provide Open Access, this journal has an Open Access fee (also known as

an article publishing charge APC) which needs to be paid by the authors

or on their behalf e.g. by their research funder or institution. The APC

is currently waived for this journal. Permitted third party (re)use is

defined by the following Creative Commons user license.

Creative Commons Attribution Non-Commercial NoDerivatives (CC BY-NC-ND)

For

non-commercial purposes, lets others distribute and copy the article,

and include in a collective work (such as an anthology) as long as they

credit the author(s) and provided they do not alter or modify the

article.

Copyright

Upon

acceptance of an article, authors will be asked to complete a

“Copyright Transfer Form”. Acceptance of the agreement will ensure the

widest possible dissemination of information. An email will be sent to

the corresponding author confirming acceptance of the manuscript

together with a “Copyright Transfer Form". Express written permission is

required for resale or distribution of this journal and its contents,

including all derivative works, compilation and/or translations. Please

contact the editorial board for all inquiries

(pieditorial@pediatricinvestigation.org). If experts from other

copyrighted works are included, the author(s) must obtain written

permission from the copyright owners and credit the source(s) in the

article.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Once

your paper is typeset you will be contacted by the editorial office to

review proof. Please note that you are responsible for all statements

made in your work, including changes made during the editorial process

and thus you must check your proofs carefully. Note that proofs should

be returned as soon as possible from receipt of first proof.

Early View

The

journal offers rapid publication via Wiley’s Early View service. Early

View (Online Version of Record) articles are published on Wiley Online

Library before inclusion in an issue. Note there may be a delay after

corrections are received before your article appears online, as Editors

also need to review proofs. Once your article is published on Early View

no further changes to your article are possible. Your Early View

article is fully citable and carries an online publication date and DOI

for citations.

8. POST PUBLICATION

Access and sharing

When your article is published online:

• You receive an email alert (if requested).

• You can share a link to your published article through social media.

You can now order print copies of your article here: www.sheridan.com/wiley/eoc (instructions are sent at proofing stage).

Article Promotion Support

Wiley

Editing Services offers professional video, design, and writing

services to create shareable video abstracts, infographics, conference

posters, lay summaries, and research news stories for your research – so

you can help your research get the attention it deserves.

Measuring the Impact of your Work

Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

Editorial office:

56 Nanlishi Road

Beijing 100045, China

Tel: +8610-66019629

Fax: +8610-66019629

E-mail: pieditorial@pediatricinvestigation.org

Author Guidelines updated Mar 2021